Nasal Decongestants – Pharmaceutical Grade APIs & Formulation Compounds | Natraj Chem

Nasal Decongestants

Pharmaceutical-Grade APIs & Formulation Compounds for Intranasal, Oral & Combination Cold-Relief Preparations – Reliable Bulk Supplier for Regulated Drug Manufacturing & OTC Healthcare Production

Nasal Decongestant Pharmaceutical APIs
Nasal Decongestant Applications

Nasal decongestants are pharmaceutical active ingredients and formulation compounds used in intranasal, oral, and combination cold-relief preparations to reduce nasal mucosal swelling and improve airflow. These agents act primarily as adrenergic receptor agonists or vasoconstrictors that constrict dilated nasal blood vessels, thereby decreasing edema, secretion volume, and sinus pressure.

Natraj Chem supplies pharmaceutical-grade decongestant actives and supporting formulation chemicals suitable for regulated drug manufacturing, contract manufacturing organizations (CMOs), and OTC healthcare product producers.

Chemical Identity

Common supplied nasal decongestant actives include:

Chemical Name Typical Class Molecular Formula CAS Number Functional Role
Oxymetazoline HCl Imidazoline derivative C₁₆H₂₄N₂O·HCl 2315-02-8 Long-acting topical vasoconstrictor
Xylometazoline HCl Sympathomimetic C₁₆H₂₄N₂·HCl 1218-35-5 Rapid nasal vasoconstriction
Phenylephrine HCl Alpha-1 agonist C₉H₁₃NO₂·HCl 61-76-7 Oral & topical decongestant
Pseudoephedrine HCl Alkaloid derivative C₁₀H₁₅NO·HCl 345-78-8 Systemic nasal decongestant

Available as API bulk powders or pre-formulation intermediates depending on manufacturing requirements.

Technical Properties

Precise physical and chemical characteristics engineered for consistent pharmaceutical performance.

Property Typical Range
Appearance White to off-white crystalline powder
Solubility Freely soluble in water; slightly soluble in alcohol (varies by compound)
pH Stability Stable between pH 4–7 (compound dependent)
Melting Point 140–182 °C
Assay (HPLC) ≥ 98.0%
Loss on Drying ≤ 0.5%
Heavy Metals ≤ 10 ppm
Microbial Limits Complies with pharmacopeial standards

Values vary by compound and grade specification.

Key Functional Benefits

Industry-leading pharmaceutical performance characteristics that set our nasal decongestant APIs apart from standard supply sources.

01
🩸

Rapid Mucosal Vasoconstriction

Effective reduction of nasal congestion through targeted adrenergic receptor action with fast clinical onset.

02
⚗️

Low Effective Dose Levels

Active in the microgram–milligram range, enabling precise and cost-efficient formulation dosing.

03
🎯

High Receptor Selectivity

Localized action minimizes systemic effects and improves the therapeutic safety profile of finished formulations.

04
🛡️

Minimal Systemic Absorption

Topical variants deliver localized relief with reduced systemic side-effect risk — ideal for OTC formulations.

05
🧪

Formulation Stability

Stable under standard pharmaceutical formulation conditions and validated packaging configurations.

06
🔗

Broad Excipient Compatibility

Compatible with isotonic buffers, benzalkonium chloride preservatives, humectants, and viscosity modifiers.

Industrial Applications

From regulated prescription pharmaceuticals to veterinary treatments — nasal decongestant APIs serve a broad spectrum of professional manufacturing sectors.

💊
Primary Application

Pharmaceutical Manufacturing

Used as active ingredients in nasal sprays, drops, inhalers, and oral tablets for rhinitis, sinusitis, and upper respiratory congestion treatment — the core application driving bulk API demand globally.

🏪
OTC Healthcare Formulations Key component in combination cold medicines containing antihistamines, analgesics, or antitussives for over-the-counter consumer markets.
🏥
Hospital Compounding & Clinical Preparations Applied in sterile nasal formulations for hospital settings requiring pharmacopeial-grade actives with stringent microbiological controls.
🏭
Contract Drug Manufacturing Bulk API supply for CMOs handling private-label production and regulatory-registered formulations at industrial scale.
🐾
Veterinary Healthcare Certain decongestant compounds adapted for animal respiratory treatments under regulated veterinary formulation protocols.
🔬
R&D & Formulation Development Small-batch and trial quantities available for pharmaceutical R&D labs and academic research institutions.

Grades / Specifications Available

Natraj Chem supplies nasal decongestant APIs in multiple pharmacopeial grades — compare and select the right specification for your manufacturing requirements.

Specification Feature 🇺🇸USP Grade 🇪🇺EP / BP Grade 🇮🇳IP Grade 🔬Micronized 🧫Low Endotoxin ⚙️Custom Grade
Pharmacopeial Monograph
Assay ≥ 98.0% (HPLC)
Certificate of Analysis (COA)
Controlled Particle Size (PSD)
Low Endotoxin Testing On Request
Custom Impurity Profile
GMP-Aligned Documentation
DMF Support Available On Request

💡 Need Help Selecting the Right Grade?

Our technical team provides expert consultation on grade selection based on your target market, regulatory pathway, and formulation requirements. Contact us to discuss your API sourcing needs and receive customized solutions.

Quality Control Parameters

Each production lot is verified through validated analytical testing before release. Our systematic QC pipeline ensures full pharmacopeial compliance at every stage.

1
2
3
4
5
6
Step 01 📊

Assay by HPLC / UV

Rigorous quantitative testing to confirm purity and active content meets pharmacopeial specification.

Purity
≥98%
Step 02 🔍

Identity Confirmation (IR, MS, NMR)

Multi-method structural verification for unambiguous compound identification and purity confirmation.

Methods
3 Methods
Step 03 🧫

Residual Solvent Analysis (GC)

ICH Q3C compliant testing for residual solvents from synthesis and purification processes.

Compliance
ICH Q3C
Step 04 ⚗️

Related Substances Profile

Comprehensive impurity quantification for regulatory compliance and formulation safety assurance.

Detection
0.05% LOQ
Step 05 💧

Moisture Content (Karl Fischer)

Precise water determination for stability and pharmaceutical formulation performance requirements.

Max Limit
≤0.5%
Step 06 🦠

Microbial Contamination Screening

Bioburden testing in full compliance with pharmacopeial microbiological limit standards.

Standard
Ph.Eur/USP

Packaging & Supply

Pharmaceutical-grade packaging formats designed for safe handling, GMP compliance, and secure supply chain integrity at every shipment scale.

🛢️
Bulk Format

HDPE Drums with Double Inner Liners

Rigid HDPE construction with dual polyethylene inner liners providing superior moisture barrier and contamination protection for bulk pharmaceutical actives.

25 kg 50 kg
Moisture Proof Double Liner GMP
🪣
Standard Format

Fiber Drums for Pharma Actives

Industry-standard fiber drums suitable for regulated drug substance handling with inner liner protection and tamper-evident closure systems.

10 kg 25 kg
GMP Compliant Tamper-Evident
🔒
Barrier Packaging

Aluminum Vacuum-Sealed Bags

Hermetic barrier packaging for moisture-sensitive and light-sensitive materials ensuring optimal stability throughout shelf life and transit.

1 kg 5 kg
Vacuum Sealed Light Barrier Hermetic
🧴
Security Format

Tamper-Evident Pharmaceutical Containers

Integrity-verified pharmaceutical-grade containers ensuring supply chain security and full GMP compliance for all pack sizes.

1 kg 5 kg
Tamper-Evident Chain of Custody

📦 Standard Pack Sizes Available

1 kg 5 kg 10 kg 25 kg 50 kg
Bulk & industrial
contracts available

Storage & Handling

Proper conditions and precautions for maintaining API quality, stability, and shelf life

Required Conditions

🌡️

Controlled Temperature

Maintain storage at 15–25 °C in a cool, dry, light-protected environment at all times.

📦

Airtight Containers

Keep containers properly sealed to prevent moisture ingress and maintain product integrity.

🏭

GMP Handling Procedures

Follow Good Manufacturing Practice material handling guidelines for all pharmaceutical actives.

Conditions to Avoid

💧

Excess Humidity & Moisture

Exposure to humid environments accelerates degradation and may affect assay values.

⚗️

Strong Acids & Oxidizing Agents

Incompatible chemical exposure (compound dependent) compromises product stability.

🔆

Direct Light & Heat

Prolonged exposure above 25 °C or to UV light accelerates chemical degradation.

📅   Shelf life typically ranges from 24–48 months when stored under recommended conditions

Regulatory / Safety Information

Manufactured in GMP-aligned facilities, conforming to pharmacopeial monographs where applicable. Full documentation provided with every shipment.

📄

Safety Data Sheet (SDS / MSDS)

Complete hazard classification, first-aid measures, handling precautions, and workplace exposure guidelines.

Every Shipment
📋

Technical Data Sheet (TDS)

Detailed specifications, validated analytical methods, and performance characteristics for technical and QA review.

On Request

Certificate of Analysis (COA)

Batch-specific quality verification with full analytical test results and pharmacopeial compliance confirmation.

Every Batch
🏛️

DMF Support Documentation

Regulatory filing support documentation for Drug Master File (DMF) submissions where applicable.

When Applicable

Why Industries Source from Natraj Chem

  • Established chemical industry expertise since 1984
  • Verified global manufacturer network with documented supplier qualification
  • Consistent batch-to-batch quality with full analytical traceability
  • Controlled sourcing and supplier qualification protocols
  • Reliable lead times for production planning and inventory management
  • Industrial-scale fulfillment capability for commercial production
  • Technical evaluation before shipment to ensure specification compliance

Natraj Chem operates as a strategic supply partner for pharmaceutical manufacturers requiring dependable raw material sourcing rather than spot-purchase trading.

Available Documentation

Complete technical and regulatory document package provided on request with every order.

  • COA — Certificate of Analysis
  • MSDS / SDS
  • TDS — Technical Data Sheet
  • Residual Solvent Reports
  • Stability Data (ICH)
  • Impurity Profile Documentation
  • Regulatory Compliance Statements
  • Method of Analysis References

Technical Support & Documentation

Our technical personnel assist with specification matching, formulation compatibility review, and regulatory submission data across these service areas:

🎯

Grade & Compound Selection

Expert guidance on choosing the optimal API and pharmacopeial grade for your target market and formulation.

🧪

Formulation Compatibility

Assessment of API suitability with your excipient systems, preservatives, and formulation platforms.

📊

Specification Matching

Tailored spec alignment to your in-house or regulatory requirements for seamless qualification.

📦

Bulk Procurement Planning

Strategic sourcing, lead-time management, and logistics coordination for production-scale volumes.

Frequently Asked Questions

Oxymetazoline HCl is commonly selected for long-acting nasal spray formulations due to its extended vasoconstrictive duration and high patient compliance profile.

Xylometazoline HCl provides fast mucosal constriction and quick relief onset, making it preferred for formulations requiring rapid symptom relief.

Most hydrochloride salt forms are highly water soluble, enabling aqueous formulations for nasal sprays, drops, and oral liquid preparations.

Typically ≥98% assay purity with full pharmacopeial compliance (USP, EP, BP, or IP) is required for OTC drug manufacturing applications.

Yes. Controlled particle size grades are available for metered-dose nasal spray systems requiring consistent spray uniformity and deposition.

Buffered saline systems, benzalkonium chloride preservatives, glycerin, and cellulose derivatives are commonly compatible with nasal decongestant APIs.

In airtight containers, protected from moisture, light, and oxidation at controlled room temperature (15–25 °C) following GMP material handling guidelines.

Prolonged exposure above recommended storage temperatures can accelerate degradation and affect assay values, making controlled storage essential.

Yes. Tailored purity levels, controlled particle size, and specific impurity limit profiles can be arranged to support formulation development requirements.

Qualified suppliers provide full documentation packages including COA, SDS, TDS, residual solvent data, and stability information for regulatory filings.

Get Technical Data & Custom Quote Today

Nasal decongestant actives are precision-grade pharmaceutical materials requiring strict quality control, validated sourcing, and consistent supply. Our team provides fast responses with full documentation — no obligation.

  • Technical datasheets (TDS) & Safety Data Sheets (SDS)
  • Certificate of Analysis (COA) samples
  • Competitive bulk pricing & volume quotes
  • Distributor / reseller partnership opportunities
  • OEM / custom manufacturing inquiries
Scroll to Top